[1] Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis. 1996;Mar27(3): 394–401.
[2] Tomasz Zapolski, Andrzej Wysokiński, Lucyna Janicka, et al. Aortic stiffness and valvular calcifications in patients with end-stage renal disease.Pol Arch Med
Wewn. 2008;118 (3):111-118.
[3] Shankar Kumar, Richard Bogle, Debasish Banerjee. Why do young people with chronic kidney disease die early? World J Nephrol. 2014; 3(4): 143-155.
[4] Wang AY, Wang M, Woo J, et al. Cardiac valve calcification as an important predictor for all-cause mortality and Cardiovascular mortality in long-term peritoneal dialysis patients: a prospective Study. J Am Soc Nephrol. 2003; 14(1): 159-168.
[5] Li W, Zhang S. Risk Factors of Parathyroid Dysfunction in Elderly Patients with Chronic Kidney Disease Undergoing Hemodialysis. Adv Clin Exp Med. 2015 Nov-Dec;24(6):1007-1012.
[6] Fedoua Ellouali, Fatimazahra Berkchi, Siham Elhoussni, et al. Evaluation of the Effect of Duration on Dialysis on Echocardiographic Parameters: A Preliminary Study. Saudi J Kidney Dis Transpl. 2015;26(1):83-89.
[7] Wilkieson TJ, Rahman MO, Gangji AS, et al. Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on Hemodialysis. Can J Kidney Health Dis. 2015;2:29.
[8] Wang AY, Woo J, Wang M, Sea MM, Ip R, Li PK, Lui SF, Sanderson JE: Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol. 2001;12: 1927–1936.
[9] RJMW Rennenberg, AGH Kessels, LJ Schurgers, et al. Vascular calcifications as a marker of increased cardiovascular risk: A meta-analysis. Vascular health and risk management. 2009;5(1):185-197.
[10] Strózecki P, Odrowaz-Sypniewska G, Manitius J. Cardiac valve calcifications And left ventricular hypertrophy in hemodialysis patients. Ren Fail. 2005;27(6): 733-738.
[11] Cottignoli V, Cavarretta E, Salvador L, et al. Morphological and Chemical study of pathological deposits in human aortic and mitral valve stenosis: abiomineralogical contribution. Patholog Res Int. 2015: 342984.
[12] Gould ST, Srigunapalan S, Simmons CA, et al. Hemodynamic and cellular response feedback in calcific aortic valve disease. Circ Res. 2013; 113(2): 186-197.
[13] Janda K, Krzanowski M, Gajda M, et al. Impaired Fasting Glucose and Diabetes as Predictors for Radial Artery Calcification in End Stage Renal Disease Patients. International Journal of Endocrinology. 2013; 2013:969038.
[14] Jorge B, Cannata Andia, Pablo Roman Garcia, et al. The connections between vascular calcification and bone health. Nephrol Dial Transplant. 2011; 26:3429-
3436.
[15] Jablonski KL, Chonchol M. Vascular Calcification in End-Stage Renal Disease. Hemodial Int. 2013;17 Suppl 1:S17-21.
[16] Arjona Barrionuevo JD, Gonzáles Vargas Machuca MF, Gómez Pulido F,et al. Transthoracic echocardiographic findings in patients with chronic kidney disease waiting kidney transplantation. Transplant Proc. 2010;42(8):3123-3125.
[17] Mark A Kraus, Philip A Kalra, John Hunter, et al. The prevalence of vascular calcification in patients with end-stage renal diseaseon hemodialysis: a cross-sectional observational study. Ther Adv Chronic Dis. 2015;6(3):84-96.
[18] Liu Y, Coresh J, Eustace JA, et al. Association Between Cholesterol Level and Mortality in Dialysis Patients: role of inflammation and malnutrition. JAMA. 2004; 291(4): 451-459.
[19] Gultekin Genctoy, Olcay Eldem, Tarkan Ergun, et al. Periaortic Fat Tissue: A Predictor of Cardiac Valvular Calcification, Malnutrition,Inflammation, and Atherosclerosis Components in Hemodialysis Patients. Artif Organs. 2015; 39(9):748-755.
[20] Webster A, Palmer S, Ruospo M, et al. Statins for end-stage kidney disease treated with dialysis. Nephrology. 2015; 20(4): 302-303.
[21] Fellström BC, Jardine AG,Schmieder RE, et al. Rosuvastatin and cardiovascularevents in patients undergoing hemodialysis.N Engl J Med. 2009;360:1395-1407.
[22] Shoji T, Emoto M, Nishizawa Y, Inaba M. Endocrine and Metabolic Changes Affecting Cardiovascular Disease in Dialysis Patients. J Ren Nutr. 2015 Mar; 25(2):223-5.
[23] Wang AY. Vascular and other tissue calcification in peritoneal dialysis patients. Perit Dial Int. 2009;29 Suppl 2:S9-S14.
[24] Liabeuf S, Desjardins L, Diouf M, et al. The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease[J]. PLOS One. 2015;10(7):e0131707.
[25] Florian Lang, Eberhard Ritz, Ioana Alesutan, et al. Impact of Aldosterone on Osteoinductive Signaling and Vascular Calcification. Nephron Physiol.2014; 128 (1-2):40-45.
[26] Shyamal Palit, Jessica Kendrick. Vascular Calcification in Chronic Kidney Disease: Role of Disordered Mineral Metabolism. Curr Pharm Des. 2014; 20(37):5829-5833.